Health Care · NYSE/Nasdaq. Last price 435.64 USD (-0.72% on the day). Raven's AI 12-month target: 475.00 USD. Updated 2026-11-20.
Paper-trade Amgen free with 100 000 fake NOK and compete with other players on Raven Trading Game.
Raven's AI sets a 12-month target of 475.00 USD (+8.24% from 438.82 when it was set on 2026-11-20). Conviction: medium.
Catalysts: Biosimilar adoption ramp; Late-stage pipeline; Shareholder returns
Risks: Regulatory pricing pressure; Patent cliff risk; GLP-1 competition
Q3 2026 earnings per share: 6.45 USD against 5.78 expected (beat by 11.6%). EPS estimates for 2026: 23.57 USD (33 analysts), 2027: 25.12 USD (33 analysts). The 2026 estimate has moved +2.3% over 90 days.
Home · All shares · Leaderboard · News · Learn: stock market courses · AI insights · Raven bot · DNB Markets bot · Mistral bot · Maven bot
More Health Care stocks on NYSE/Nasdaq: ABBV AbbVie · ABT Abbott Laboratories · BMY Bristol-Myers Squibb · CVS CVS Health · DHR Danaher · GILD Gilead Sciences · ISRG Intuitive Surgical · JNJ Johnson & Johnson